By Associate Professor Julia Lappin

Books

Darke S; Lappin J; Farrell M, 2021, The pocket guide to drugs and health, Silverback, London

Darke S; Lappin J; Farrell M, 2019, The Clinician's Guide to Illicit Drugs and Health, Silverback Publishing, Great Britain, https://www.silverbackpublishing.org/products/the-clinicians-guide-to-illicit-drugs-and-health

Book Chapters

Lappin J; Onwumere J; Murray R, 2024, 'Understanding Psychosis and Schizophrenia', in Coping with Psychosis and Schizophrenia, Cambridge University Press, pp. 1 - 12, http://dx.doi.org/10.1017/9781911623700.003

Dazzan P; Morgan K; Lappin J; Fearon P, 2012, 'Neuroimaging and psychosis: Are brain changes in individuals with psychosis neurodevelopmental for some and progressive for others?', in Schizophrenia: The Final Frontier - A Festschrift for Robin M. Murray, pp. 147 - 154, http://dx.doi.org/10.4324/9780203808771

Laurens K; Hodgins S; Taylor EA; Murray RM, 2011, 'Is earlier intervention for schizophrenia possible? Identifying antecedents of schizophrenia in children aged 9-12 years', in David AS; Kapur S; McGuffin P (ed.), Schizophrenia: The Final Frontier - A Festschrift for Robin M. Murray, Psychology Press Ltd, Taylor & Francis Press, pp. 19 - 32

Ebmeier KP; Lappin JM, 2002, 'Electromagnetic Stimulation and Affective Disorders<footref rid="foot01">¹</footref>', in Advances in Biological Psychiatry, KARGER, pp. 167 - 177, http://dx.doi.org/10.1159/000066883

Ebmeier KP; Lappin JM, 2001, 'Electromagnetic stimulation in psychiatry', in , pp. 181 - 188, http://dx.doi.org/10.1192/apt.7.3.181

Journal articles

Rubaiya Talukder S; Lappin J; Clare Boland V; Weaver N; McRobbie H; James Courtney R, 2024, 'Mental health related adverse events of cytisine and varenicline in smokers with and without mental health disorders: Secondary analysis of a randomized controlled trial', Addictive Behaviors, 159, http://dx.doi.org/10.1016/j.addbeh.2024.108148

Talukder S; Lappin JM; Boland VC; Weaver N; McRobbie H; Courtney RJ, 2024, 'Receipt of the 5As intervention for smoking cessation among people with and without mental health disorders', Journal of Psychiatric Research, 179, pp. 1 - 7, http://dx.doi.org/10.1016/j.jpsychires.2024.08.023

Grattan S; Davies K; Weise J; Burns N; Murray R; Weldon J; Ellis R; Lappin JM, 2024, 'Development of a framework of the skills and attributes needed by mental health professionals to provide optimal clinical care to people experiencing complex psychosis: A Delphi consensus study.', Aust N Z J Psychiatry, pp. 48674241289032, http://dx.doi.org/10.1177/00048674241289032

Lappin JM, 2024, 'Rare but relevant: Methamphetamine and Parkinson's disease.', Addiction, http://dx.doi.org/10.1111/add.16695

Darke S; Duflou J; McDonald S; Peacock A; Farrell M; Lappin J, 2024, 'Neuropathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Dependence, 263, http://dx.doi.org/10.1016/j.drugalcdep.2024.111407

Darke S; Duflou J; Peacock A; Farrell M; Hall W; Lappin J, 2024, 'A retrospective study of the characteristics and toxicology of cases of lysergic acid diethylamide (LSD)- and psilocybin-related death in Australia', Addiction, 119, pp. 1564 - 1571, http://dx.doi.org/10.1111/add.16518

Davies K; Lappin JM; Gott C; Steel Z, 2024, 'Experiencing Psychosis and Shame: A Systematic Review and Meta-analysis of the Strength and Patterns of Association.', Schizophr Bull, http://dx.doi.org/10.1093/schbul/sbae139

Lappin JM, 2024, 'Can we raise the bar?', Australian and New Zealand Journal of Psychiatry, 58, pp. 633 - 635, http://dx.doi.org/10.1177/00048674241269077

Darke S; Farrell M; Duflou J; Lappin J, 2024, 'Chronic obstructive pulmonary disease in heroin users: An underappreciated issue with clinical ramifications', Addiction, 119, pp. 1153 - 1155, http://dx.doi.org/10.1111/add.16407

Bolton P; Davies K; Grattan S; Lappin JM, 2024, 'Commando care for individuals living with severe mental illness: Equally Well goes beyond metabolic health alone', Australian and New Zealand Journal of Psychiatry, 58, pp. 545 - 548, http://dx.doi.org/10.1177/00048674241240601

Darke S; Duflou J; Peacock A; Chrzanowska A; Yuen WS; Farrell M; Lappin J, 2024, 'Characteristics, toxicology and major organ pathology of deaths due to acute alcohol toxicity in Australia, 2011–2022', Drug and Alcohol Review, 43, pp. 937 - 945, http://dx.doi.org/10.1111/dar.13817

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'A descriptive coronial study of heroin toxicity deaths in Australia, 2020–2022: Characteristics, toxicology and survival times', Addiction, 119, pp. 559 - 569, http://dx.doi.org/10.1111/add.16377

Weickert TW; Jacomb I; Lenroot R; Lappin J; Weinberg D; Brooks WS; Brown D; Pellen D; Kindler J; Mohan A; Wakefield D; Lloyd AR; Stanton C; O'Donnell M; Liu D; Galletly C; Shannon Weickert C, 2024, 'Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trial', Brain, Behavior, and Immunity, 115, pp. 191 - 200, http://dx.doi.org/10.1016/j.bbi.2023.10.012

Darke S; Duflou J; Chrzanowska A; Farrell M; Lappin J; Peacock A, 2024, 'Changes in the rates and characteristics of gamma hydroxybutyrate (GHB)-related death in Australia, 2001–2023', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13940

Macdonald C; Weatherburn D; Lappin J, 2024, 'Diversion into mental health treatment: a survey of magistrates and treatment plans', Psychiatry, Psychology and Law, http://dx.doi.org/10.1080/13218719.2024.2313985

Darke S; Duflou J; Farrell M; Lappin J; Peacock A, 2024, 'Emergence of deaths due to nitazene toxicity in Australia', Drug and Alcohol Review, http://dx.doi.org/10.1111/dar.13920

Darke S; Farrell M; Lappin J, 2024, 'Rare but relevant series', Addiction, http://dx.doi.org/10.1111/add.16697

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2024, 'Differences in heroin overdose deaths in Australia by age, 2020-2022: Disease and estimated survival times.', Drug Alcohol Depend Rep, 10, pp. 100217, http://dx.doi.org/10.1016/j.dadr.2024.100217

Gott CA; Thomas M; Allan J; Kennedy J; Black Y; Dark F; Lappin JM, 2023, 'Cognitive remediation therapy – implementation and translation into clinical practice in rural and metropolitan New South Wales mental health services', Australasian Psychiatry, 31, pp. 584 - 586, http://dx.doi.org/10.1177/10398562231186125

Pollard R; Fisher HL; Fearon P; Morgan K; Lappin J; Hutchinson G; Doody GA; Jones PB; Murray RM; Morgan C; Dazzan P, 2023, 'Parental bonding style and illness severity in a longitudinal study of individuals with first episode psychosis', Archives of Women's Mental Health, 26, pp. 707 - 711, http://dx.doi.org/10.1007/s00737-023-01351-y

Davies K; Grattan S; Gott C; Ellis R; Lappin JM, 2023, 'The tertiary service for psychosis: Holistic recommendations for people with complex psychosis', Australasian Psychiatry, 31, pp. 591 - 597, http://dx.doi.org/10.1177/10398562231189115

Darke S; Farrell M; Lappin J, 2023, 'Overdose and suicide are different phenomena among opioid users that require different clinical management', Australian and New Zealand Journal of Psychiatry, 57, pp. 1095 - 1100, http://dx.doi.org/10.1177/00048674231159298

Talukder SR; Lappin JM; Boland V; McRobbie H; Courtney RJ, 2023, 'Inequity in smoking cessation clinical trials testing pharmacotherapies: exclusion of smokers with mental health disorders', Tobacco Control, 32, pp. 489 - 496, http://dx.doi.org/10.1136/tobaccocontrol-2021-056843

Srasuebkul P; Walker AR; Cvejic RC; Trollor JN; Lappin JM; Curtis J; Samaras K; Dean K; Ward PB; Reppermund S, 2023, 'Hospital service utilisation of people previously hospitalised with different subtypes of psychotic disorder: A record linkage study', Australian and New Zealand Journal of Psychiatry, 57, pp. 844 - 853, http://dx.doi.org/10.1177/00048674221115642

Lappin JM; Darke S; Farrell M, 2023, 'Psychotogenic potential of prescribed drugs', Australian and New Zealand Journal of Psychiatry, 57, pp. 777 - 779, http://dx.doi.org/10.1177/00048674231174807

Foley C; Allan J; Lappin J; Courtney R; Farnbach S; Henderson A; Shakeshaft A, 2023, 'Utilising the Implementation of Integrated Care to Develop a Pragmatic Framework for the Sustained Uptake of Service Innovations (SUSI)', Healthcare (Switzerland), 11, http://dx.doi.org/10.3390/healthcare11121786

Davies K; Courtney RJ; Summersby-Mitchell M; Morell R; Briggs N; Lappin JM, 2023, 'A systematic review of factors associated with sustained smoking abstinence in people experiencing severe mental illness following participation in a smoking intervention', Australian and New Zealand Journal of Psychiatry, 57, pp. 489 - 510, http://dx.doi.org/10.1177/00048674221147206

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of cocaine-related completed suicide in Australia, 2000–2021', Drug and Alcohol Dependence, 244, http://dx.doi.org/10.1016/j.drugalcdep.2023.109803

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Clinical characteristics of fatal cocaine toxicity in Australia, 2000–2021', Drug and Alcohol Review, 42, pp. 582 - 591, http://dx.doi.org/10.1111/dar.13581

Darke S; Duflou J; Peacock A; Chrzanowska A; Farrell M; Lappin J, 2023, 'Rates, characteristics and toxicology of cocaine-related deaths in Australia, 2000–2021', Addiction, 118, pp. 297 - 306, http://dx.doi.org/10.1111/add.16055

Cohn SL; Mohan A; Lappin JM; Curtis J; Scott JG, 2023, 'Anti-N-Methyl-D-Aspartate Receptor Antibody Testing in First-Episode Psychosis: Universal or Targeted Testing', Journal of Neuropsychiatry and Clinical Neurosciences, 35, pp. 98 - 101, http://dx.doi.org/10.1176/appi.neuropsych.21080214

Darke S; Zahra E; Duflou J; Peacock A; Farrell M; Lappin J, 2023, 'Characteristics and circumstances of volatile solvent misuse-related death in Australia, 2000–2021', Clinical Toxicology, 61, pp. 260 - 265, http://dx.doi.org/10.1080/15563650.2023.2184243

Davies K; Gott C; Ferdman A; Lloyd K; Pnevmatikos N; Chase E; Lappin J, 2023, 'Promoting psychological interventions in psychosis: the NSW Tertiary Referral Service for Psychosis', Australian Psychologist, 58, pp. 315 - 320, http://dx.doi.org/10.1080/00050067.2023.2211759

Lappin JM; Zahra E; Darke S; Shand F; Sharma S; Draper B; Connors MH; Dear B; Titov N; Campbell G, 2022, 'Presentations to the emergency department with self-harm or suicidal behaviours: A role for digital mental health services?', Journal of Psychiatric Research, 154, pp. 50 - 55, http://dx.doi.org/10.1016/j.jpsychires.2022.07.046

Lappin JM; Davies K; O'Donnell M; Walpola IC, 2022, 'Underuse of recommended treatments among people living with treatment-resistant psychosis', Frontiers in Psychiatry, 13, http://dx.doi.org/10.3389/fpsyt.2022.987468

O'Dea D; Curtis J; Scully A; Lappin J, 2022, 'A pilot study of a mindfulness informed yoga intervention in young people with psychosis', Early Intervention in Psychiatry, 16, pp. 1036 - 1042, http://dx.doi.org/10.1111/eip.13264

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal tapentadol-related toxicity in Australia', Drug and Alcohol Review, 41, pp. 1071 - 1077, http://dx.doi.org/10.1111/dar.13462

Darke S; Chrzanowska A; Campbell G; Zahra E; Lappin J, 2022, 'Barbiturate-related hospitalisations, drug treatment episodes, and deaths in Australia, 2000‒2018', Medical Journal of Australia, 216, pp. 194 - 198, http://dx.doi.org/10.5694/mja2.51306

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia', Drug and Alcohol Dependence, 232, http://dx.doi.org/10.1016/j.drugalcdep.2022.109292

Lappin J, 2022, 'Clinical Management of Withdrawal Series', Addiction, 117, pp. 517, http://dx.doi.org/10.1111/add.15708

Darke S; Peacock A; Duflou J; Farrell M; Lappin J, 2022, 'Characteristics of fatal ‘novel’ benzodiazepine toxicity in Australia', Forensic Science International, 331, http://dx.doi.org/10.1016/j.forsciint.2021.111140

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2022, 'Characteristics of fatal gabapentinoid-related poisoning in Australia, 2000–2020', Clinical Toxicology, 60, pp. 304 - 310, http://dx.doi.org/10.1080/15563650.2021.1965159

Lappin JM, 2022, 'Comorbid substance use in psychosis: Someone else’s problem?', Australian and New Zealand Journal of Psychiatry, 56, pp. 5 - 7, http://dx.doi.org/10.1177/00048674211065669

Back to profile page